Spirometric analysis between FHP and control groups
FHP group (n = 45) | non-FHP group (n = 15) | ||||||
---|---|---|---|---|---|---|---|
Units | Mean | Median | SD | Mean | Median | SD | |
FVC | L | 99.73 | 97 | 11.83 | 99.2 | 104 | 15.53 |
FEV1 | L | 100.62 | 101 | 9.41 | 102.67 | 106 | 20.87 |
Tiffenau | % | 84.06 | 84 | 6.00 | 83.28 | 83.9 | 5.65 |
PEF | L/s | 100.42 | 101 | 12.76 | 96.33 | 99 | 19.40 |
MEF25 | L/s | 97.96 | 98 | 22.89 | 113.47 | 114 | 52.07 |
MEF50 | L/s | 99.38 | 97 | 20.72 | 111.87 | 106 | 40.17 |
MEF75 | L/s | 98.51 | 96 | 18.57 | 100 | 105 | 25.61 |
FEF25–75 | L/s | 100.44 | 103 | 17.97 | 113.27 | 107 | 39.95 |
VC | L | 96.13 | 95 | 13.15 | 94.47 | 100 | 17.15 |
IC | L | 92.82 | 89 | 13.62 | 100.8 | 100 | 16.10 |
MVV | L/min | 104.87 | 105 | 19.17 | 98.4 | 102 | 25.84 |
FS, SP, and AB: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. TDF, DT, A Serio, A Spinelli, and LC: Conceptualization, Investigation, Writing—original draft, Writing—review & editing. AD, GA, EK, and CMG: Validation, Writing—review & editing, Supervision. All authors read and approved the submitted version.
The authors declare that they have no conflicts of interest.
This study complies with the Declaration of Helsinki.
Informed consent to participate in the study was obtained from all participants.
Consent to publish his photograph was obtained from the subject in the picture.
Not applicable.
Not applicable.
© The Author(s) 2023.